Atticus Advisors

About Us

Contact Form Demo
Healthcare

About Us

Biosimilars are increasingly becoming the mandated first-line treatment across multiple therapies globally, and increased access to these in India would lead to a paradigm shift in treatment strategies. The role of biosimilars has become critical in the management of patients with cancer and is extending to different therapy areas like dermatology, rheumatology, and cardiology. They offer to improve patients’ accessibility to effective, affordable medical treatment.

India is at the cusp of transforming towards this paradigm shift in healthcare, with a large number of biopharmaceutical companies invested in developing biosimilars of established MABs which are due patent expiry in the coming years. This is also reflected in the market analysis which has projected the overall Biosimilar healthcare market to be around $2108 Mn in 2030, rising steadily from $349 Mn in 2022.

Healthcare

At Atticus Healthcare, we are dedicated to advancing healthcare in through strategic and innovative Medical solutions. With a deep-rooted commitment to scientific excellence and patient-centricity, we strive to support pharmaceutical, biotechnology, and medical device companies in navigating the complex landscape of healthcare.Atticus Advisors offers a comprehensive suite of solutions tailored to meet the evolving needs of our clients through experience & insights in areas like adoption of Biosimilars in Oncology, Management of different Cancers and other therapy areas like Vaccine & Critical Care.

Healthcare

Who we Are

Dr Sagar Sharma

Director, Atticus Healthcare

Dr Sagar was associated with Abbott Healthcare for 5 years where he lead the national medical team in set up and running Oncology Therapy area . He also contributed to development of their Biosimilar Pipeline at Abbott, mapping the landscape of a drug in India. He has a rich & diverse experience of over 14 years including his time in MNCs like Roche & Sanofi Pasteur contributing to some first time in India Molecule launches in Oncology & Vaccines as well as Academia and Critical care. He has an MBBS and MD Pharmacology.

Partho Sarathi Ghosh

CEO, Atticus Healthcare

Partho Sarathi Ghosh is the Founder, CEO of Atticus Advisors. He has been leading the Strategy Consulting function, working with MNCs, Startups, non profits and Mid size Businesses. His primary area of expertise lies in corporate strategy, which enables him to work on Transformation, Management Consulting, Data analytics, Project management and profitability related projects. He has 8+ years experience catering to clients from Retail, Pharma, financial Services, Manufacturing and Ed tech. He has worked extensively in India as well as US, Australia, Singapore and Malaysia. He has a B Tech in Electrical Engineering and MBA in Finance from NMIMS, Mumbai.

Make An Appointment Today

We have an excellent team to give you the best service of caregiving and take care of your loved ones. If you want to explore more about us and give us a chance to get you our finest service, book an appointment today and become a part of our community.
Healthcare